Literature DB >> 12217326

Multiple Cdk1 inhibitory kinases regulate the cell cycle during development.

Walter Leise1, Paul R Mueller.   

Abstract

The Wee kinases block entry into mitosis by phosphorylating and inhibiting the activity of the mitotic cyclin-dependent kinase, Cdk1. We have found that the various Xenopus Wee kinases have unique temporal and spatial patterns of expression during development. In addition, we have isolated and characterized a new Wee1-like kinase, Xenopus Wee2. By both in vivo and in vitro tests, Xenopus Wee2 functions as a Wee1-like kinase. The previously isolated Wee1-like kinase, Xenopus Wee1, is expressed only as maternal gene product. In contrast, Xenopus Wee2 is predominantly a zygotic gene product, while the third Wee kinase, Xenopus Myt1, is both a maternal and zygotic gene product. Concurrent with the changing levels of these Cdk inhibitory kinases, the pattern of embryonic cell division becomes asynchronous and spatially restricted in the Xenopus embryo. Interestingly, once zygotic transcription begins, Xenopus Wee2 is expressed in regions of the embryo that are devoid of mitotic cells, such as the involuting mesoderm. In contrast, Xenopus Myt1 is expressed in regions of the embryo that have high levels of proliferation, such as the developing neural tissues. The existence of multiple Wee kinases may help explain how distinct patterns of cell division arise and are regulated during development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217326     DOI: 10.1006/dbio.2002.0743

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  16 in total

1.  Filamin a regulates neural progenitor proliferation and cortical size through Wee1-dependent Cdk1 phosphorylation.

Authors:  Gewei Lian; Jie Lu; Jianjun Hu; Jingping Zhang; Sally H Cross; Russell J Ferland; Volney L Sheen
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

2.  Multiscale analysis of architecture, cell size and the cell cortex reveals cortical F-actin density and composition are major contributors to mechanical properties during convergent extension.

Authors:  Joseph H Shawky; Uma L Balakrishnan; Carsten Stuckenholz; Lance A Davidson
Journal:  Development       Date:  2018-10-05       Impact factor: 6.868

Review 3.  Cdc25 and the importance of G2 control: insights from developmental biology.

Authors:  Cortney M Bouldin; David Kimelman
Journal:  Cell Cycle       Date:  2014-06-10       Impact factor: 4.534

4.  Regulation of oocyte meiotic maturation by somatic cells.

Authors:  Masayuki Shimada
Journal:  Reprod Med Biol       Date:  2012-05-12

5.  Multisite M-phase phosphorylation of Xenopus Wee1A.

Authors:  Sun Young Kim; Eun Joo Song; Kong-Joo Lee; James E Ferrell
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

6.  A conserved role for retinoid signaling in vertebrate pancreas development.

Authors:  D Stafford; A Hornbruch; P R Mueller; V E Prince
Journal:  Dev Genes Evol       Date:  2004-08-18       Impact factor: 0.900

7.  M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP.

Authors:  Nobumoto Watanabe; Harumi Arai; Yoshifumi Nishihara; Makoto Taniguchi; Naoko Watanabe; Tony Hunter; Hiroyuki Osada
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-22       Impact factor: 11.205

8.  Zebrafish cdc25a is expressed during early development and limiting for post-blastoderm cell cycle progression.

Authors:  Damian E Dalle Nogare; Andrea Arguello; Shelley Sazer; Mary Ellen Lane
Journal:  Dev Dyn       Date:  2007-12       Impact factor: 3.780

9.  Drosophila myt1 is the major cdk1 inhibitory kinase for wing imaginal disc development.

Authors:  Zhigang Jin; Ellen Homola; Stanley Tiong; Shelagh D Campbell
Journal:  Genetics       Date:  2008-10-20       Impact factor: 4.562

Review 10.  Second meiotic arrest and exit in frogs and mice.

Authors:  Anthony C F Perry; Marie-Hélène Verlhac
Journal:  EMBO Rep       Date:  2008-03       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.